Name: Scimago Journal Rankings
Creator: Scimago Lab
Keywords: scientific information, scopus, journals, authors, citation, impact factor, science, scientometrics, bibliometrics

Only Open Access Journals Only SciELO Journals Only WoS Journals Web of Science Core Collection: A&HCI, SCI, SSCI and ESCI. Retrieved 19 April 2021 from http://mjl.clarivate.com

Web of Science Core Collection: A&HCI, SCI, SSCI and ESCI. Retrieved 19 April 2021 from http://mjl.clarivate.com

Display journals with at least Apply

Download data

1 - 15 of 15

	Title	Type	SJR	H index	Total Docs. (2013)	Total Docs. (3years)	Total Refs. (2013)	Total Cites (3years)	Citable Docs. (3years)	Cites / Doc. (2years)	Ref. / Doc. (2013)
1	Progress in Drug Research	book series	2.162 Q1	46	0	15	0	72	13	4.80	0.00
2	Advances in Molecular Toxicology	book series	0.371 Q3	18	7	23	939	34	6	1.20	134.14
3	Topics in Medicinal Chemistry	book series	0.366 Q3	15	0	32	0	18	24	0.94	0.00
4	Studies in Natural Products Chemistry	book series	0.246 Q3	49	29	40	3674	26	2	0.65	126.69
5	IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer	book series	0.285 Q4	50	45	170	6173	171	162	0.60	137.18
6	Neuromethods	book series	0.234 Q2	24	145	493	9977	168	427	0.35	68.81
7	Issues in Toxicology	book series	0.160 Q4	18	40	122	8309	50	114	0.27	207.73
8	Strategies and Tactics in Organic Synthesis	book series	0.162 Q4	10	13	17	891	3	0	0.18	68.54
9	Methods in Pharmacology and Toxicology	book series	0.112 Q4	14	0	44	0	7	41	0.16	0.00
10	Milestones in Drug Therapy	book series	0.122 Q4	6	31	108	2911	15	105	0.15	93.90
11	Frontiers in Medicinal Chemistry	book series	0.101 Q4	7	0	32	0	1	14	0.06	0.00
12	NTP Technical Report on the Toxicology and Carcinogenesis Studies Series	book series		9	4	28	749	0	28	0.00	187.25
13	Report on carcinogens. Monograph on ..	book series		2	2	0	0	0	0	0.00	0.00
14	RSC Drug Discovery Series	book series	0.102 Q4	13	0	28	0	0	11	0.00	0.00
15	Side Effects of Drugs Annual	book series	0.100 Q4	9	0	157	0	1	8	0.00	0.00

1 - 15 of 15